Venture Partner

Ian Peikon, PhD

featured investment

Ian Peikon, PhD
featured investment

About

Ian Peikon, PhD

Ian is a molecular biologist, engineer, and entrepreneur. He has been involved in the formation and early company building of Lux portfolio companies including Kallyope as well as several other stealth Newcos.

Before joining Lux, Ian was the Head of Platform Biology & Technology at Kallyope, where he led a team of molecular biologists, neuroscientists, and data scientists in the discovery of new therapeutic targets that harness the gut-brain axis.

Prior, Ian worked on neuroprosthetics and brain-machine interfaces at Duke University with Miguel Nicolelis, later completing his PhD at Cold Spring Harbor Laboratory, where he developed novel tools to map connectivity in the brain by leveraging high-throughput DNA sequencing.

Ian is currently the Co-founder and Chief Scientific Officer of Cajal Neuroscience, a Lux-incubated portfolio company.

Image credit goes here
Image credit goes here
companies invested in

Kallyope

Advancing Human Health
Image credit goes here
Image credit goes here
It's a fact

See what

Ian Peikon, PhD

has to say

No items found.
connect
Don’t miss a thought.

Meet more of the team